Nov. 14 at 5:02 PM
Noble Capital Markets Research Report: The Oncology Institute, Inc. (
$TOI) – Guidance Raised After 3Q25 Revenues Beat Expectations
3Q25 Was A Strong Quarter. The Oncology Institute reported a loss of
$16.5 million or $(0.14) per share, with revenues from Patient Services and Dispensary both ahead of our estimates. Adjusted EBITDA turned positive for the first time at the end of the quarter. Management raised guidance for Full-Year Revenues, and confirmed the ranges for Adjusted EBITDA, and Free Cash Flow. On September 30, the company had
$27.7 million in cash.
Read more: https://www.channelchek.com/news-channel/the-oncology-institute-inc-toi-guidance-raised-after-3q25-revenues-beat-expectations
